Mon, 27 Apr 2009 15:13:03 -0400 PeerView Press http://www.peerviewpress.com Podcast Maker v1.3.8b - http://www.lemonzdream.com/podcastmaker Thought leader perspectives on current clinical advances in medicine. PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes. 2007 PeerView Press,24 West 40th Street, Suite 950, New York, NY 10018 webmaster@peerviewpress.com http://podcast.peerviewpress.com/PulmonologyVideoUS/vidPulmonologyCME-CNE-CPE_144.jpg http://www.peerviewpress.com 144 144 Science & Medicine CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Rheumatology no PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this activity, experts in the management of COPD debate on how to optimize current management of COPD and what to expect from emerging therapies. They also discuss the most up-to-date evidence on the use of combination strategies and various formulation options. Finally, they offer their own insights into the value of early intervention and approaches to patients with COPD who continue to smoke. http://podcast.peerviewpress.com/PulmonologyVideoUS/PA05116FCe022.m4v http://podcast.peerviewpress.com/PulmonologyVideoUS/PA05116FCe022.m4v Tue, 25 Nov 2008 09:52:08 -0500 Science, Medicine no 00:32:48 COPD, chronic obstructive pulmonary disease, LABA, LAMA, long-acting bronchodilators, PDE-IV inhibitors, formoterol, tiotropium, asthma PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/PulmonologyVideoUS/PA05116FCCMEinfo.pdf http://podcast.peerviewpress.com/PulmonologyVideoUS/PA05116FCCMEinfo.pdf Tue, 25 Nov 2008 09:52:08 -0500 Science, Medicine no 00:00:00 COPD, chronic obstructive pulmonary disease, LABA, LAMA, long-acting bronchodilators, PDE-IV inhibitors, formoterol, tiotropium, asthma PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. This CME activity reviews the risk factors of AAT deficiency and strategies to prevent disease progression. Strategies for improving detection and management of the disorder are also highlighted. http://podcast.peerviewpress.com/PulmonologyVideoUS/PA04233FCr400.m4v http://podcast.peerviewpress.com/PulmonologyVideoUS/PA04233FCr400.m4v Tue, 26 Aug 2008 16:29:42 -0400 Science no 00:24:30 alpha1-Antitrypsin, AAT, proteases, emphysema, bronchiectasis, panniculitis, COPD, lung cancer, augmentation, alpha-1 proteinase inhibitor (human) PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/PulmonologyVideoUS/PA04233FCCMEinfo.pdf http://podcast.peerviewpress.com/PulmonologyVideoUS/PA04233FCCMEinfo.pdf Tue, 26 Aug 2008 16:29:25 -0400 Science no 00:00:00 alpha1-Antitrypsin, AAT, proteases, emphysema, bronchiectasis, panniculitis, COPD, lung cancer, augmentation, alpha-1 proteinase inhibitor (human) PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. The latest data and guidelines are applied to the control of asthma in the clinic through instructive case studies presented by Dr. Marcus. http://podcast.peerviewpress.com/PulmonologyVideoUS/PA03462FC2p114.mp3 http://podcast.peerviewpress.com/PulmonologyVideoUS/PA03462FC2p114.m4v Mon, 03 Mar 2008 15:46:42 -0500 Science no 00:37:55 Asthma, COPD, IgE, pulmonology, EPR-3, FEV1, omalizumab, anaphylaxis PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file http://podcast.peerviewpress.com/PulmonologyVideoUS/PA03462FC2CMEinfo.pdf http://podcast.peerviewpress.com/PulmonologyVideoUS/PA03462FC2CMEinfo.pdf Mon, 03 Mar 2008 15:45:42 -0500 Science no 00:00:00 Asthma, COPD, IgE, pulmonology, EPR-3, FEV1, omalizumab, anaphylaxis PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this CME activity, experts in the treatment of COPD present recent data on current and emerging agents used to treat this disease. Survival benefits and safety of these agents are also discussed. Current and emerging delivery systems are also highlighted. http://podcast.peerviewpress.com/PulmonologyVideoUS/PA04161FCr358.m4v http://podcast.peerviewpress.com/PulmonologyVideoUS/PA04161FCr358.m4v Wed, 20 Feb 2008 15:52:30 -0500 Science no 00:24:35 COPD, chronic obstructive pulmonary disease, bronchitis, anticholinergics, short-acting beta-agonists, long-acting beta-agonist, beta adrenoceptor agonists, albuterol, levabuterol, ipratropium bromide PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file http://podcast.peerviewpress.com/PulmonologyVideoUS/PA04161FCCMEinfo.pdf http://podcast.peerviewpress.com/PulmonologyVideoUS/PA04161FCCMEinfo.pdf Wed, 20 Feb 2008 15:52:02 -0500 Science no 00:00:00 COPD, chronic obstructive pulmonary disease, bronchitis, anticholinergics, short-acting beta-agonists, long-acting beta-agonist, beta adrenoceptor agonists, albuterol, levabuterol, ipratropium bromide PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this program, an expert will discuss how to diagnose, monitor, and treat patients with difficult-to-control asthma. Patient scenarios are used to illustrate how to apply current evidence and latest treatment guidelines to everyday practice. http://podcast.peerviewpress.com/PulmonologyVideoUS/PA03778FCp131.m4v http://podcast.peerviewpress.com/PulmonologyVideoUS/PA03778FCp131.m4v Wed, 09 Jan 2008 16:35:33 -0500 Science no 00:24:47 Asthma, pulmonology PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file http://podcast.peerviewpress.com/PulmonologyVideoUS/PA03788FCCMEinfo.pdf http://podcast.peerviewpress.com/PulmonologyVideoUS/PA03788FCCMEinfo.pdf Wed, 09 Jan 2008 16:35:30 -0500 Science no 00:00:00 CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Pulmonology PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this program, experts present up-to-date information on optimal management of asthma. Clinical challenges in the treatment of asthma are discussed and new concepts related to asthma control are assessed. Changes in the latest asthma guidelines are summarized, as well as the step-wise algorithm for use of asthma therapies. http://podcast.peerviewpress.com/PulmonologyVideoUS/PA03462FC1r246.m4v http://podcast.peerviewpress.com/PulmonologyVideoUS/PA03462FC1r246.m4v Tue, 30 Oct 2007 11:52:30 -0400 Science & Medicine no 00:31:59 Asthma, NAEPP, guidelines, NHBLI, IgE, IgE-mediated asthma, allergic asthma, anti-IgE therapy, biologics therapy, omalizumab, Xolair, steroid-resistant asthma PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/PulmonologyVideoUS/PA03462FC1CMEinfo.pdf http://podcast.peerviewpress.com/PulmonologyVideoUS/PA03462FC1CMEinfo.pdf Tue, 30 Oct 2007 11:52:28 -0400 Science & Medicine no 00:00:00 Asthma, NAEPP, guidelines, NHBLI, IgE, IgE-mediated asthma, allergic asthma, anti-IgE therapy, biologics therapy, omalizumab, Xolair, steroid-resistant asthma PVI, PeerView Institute for Medical Education Please be sure to view the accompanying (PDF) file for full CME/CE information. In this interactive activity, an expert in the management of pulmonary arterial hypertension (PAH) presents three cases, by examining criteria that establish clinical status and the diagnosis of PAH. In addition, clinical-trial data are presented regarding the efficacy and safety of available and emerging therapies for this condition. http://podcast.peerviewpress.com/PulmonologyVideoUS/PA03751FCp115.m4v http://podcast.peerviewpress.com/PulmonologyVideoUS/PA03751FCp115.m4v Thu, 26 Jul 2007 16:25:30 -0400 Science & Medicine no 00:54:58 6-minute–walk distance, Ambrisentan, Bosentan, Cardiac catheterization, Echocardiography, endothelin-receptor antagonists, Epoprostenol, Hypertension, pulmonary arterial, Iloprost, Phosphodiesterase inhibitor, Prostacyclin, Raynaud's phenomenon PVI, PeerView Institute for Medical Education Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. Please view this PDF file for full CME/CE information. You will need Adobe Acrobat reader software to access this file. http://podcast.peerviewpress.com/PulmonologyVideoUS/PA03751FCCMEinfo.pdf http://podcast.peerviewpress.com/PulmonologyVideoUS/PA03751FCCMEinfo.pdf Thu, 26 Jul 2007 16:25:25 -0400 Science & Medicine no 00:00:00 6-minute–walk distance, Ambrisentan, Bosentan, Cardiac catheterization, Echocardiography, endothelin-receptor antagonists, Epoprostenol, Hypertension, pulmonary arterial, Iloprost, Phosphodiesterase inhibitor, Prostacyclin, Raynaud's phenomenon